Treo Ventures, Llc
Venture capitalMinneapolis · Seed–Late Stage · 5 people tracked
Investment thesis
Treo Ventures invests in medical device and digital health companies whose innovations can meaningfully improve human life. It targets startups based in the US and Europe, operating from offices in Silicon Valley and Ireland. The portfolio emphasizes clinical-stage medical technologies, notably neuromodulation and implantable bioelectronic devices, cardiovascular therapies, orthopedic materials, and treatments for conditions such as migraine, restless legs syndrome, urinary urge incontinence, and venous disorders.
Source: firm website, verified Aug 25, 2026.
Team · 5 people
from the firm's website
What they invest in
from 13 of 14 portfolio companiesMedical Devices ×12Healthtech ×10Biotech ×6Deep Tech ×3Digital Health ×2Hardware ×2Advanced Manufacturing ×1Circular Economy ×1
HQs:United States×12
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 42021 · 12020 · 16 dated
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
BoardGeoff Pardo(Director)
Co-investorsNew Enterprise Associates (NEA)Windham Capital PartnersYsios CapitalHatteras Venture PartnersVensana Capital
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.
BiotechDeep TechHealthtechMedical DevicesRoseville, US
Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)Stephen Masson(Executive Officer, Director)
BoardTheresa C. Pappas(Director)Ketan Patel(Director)in
Co-investorsHatteras Venture PartnersF-Prime Capital
iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.
BiotechHealthtechMedical DevicesMinneapolis, US
Mudit K. Jain(Co-Founder and Chairman of the Board)Lynn Elliott(Co-Founder and Director)Steve Masson(President & CEO)
Co-investorsHatteras Venture PartnersF-Prime Capital
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.
HealthtechMedical DevicesLexington, US
Carl Vause(Executive Officer, Director)Mira Sahney(Executive Officer, Director)David Myung(Director)
BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in
Board seatBrad H. Vale· per SEC Form D
Co-investorsCanaan PartnersOUP (Osage University Partners)
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)in
Board seatMudit JainTracy Pappas· per SEC Form D
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedZühlke VenturesBridge BankSandbox Clinical Ventures+1 more
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)
Board seatBrad H. ValeMudit Jain· per SEC Form D
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions.
BiotechHealthtechMedical DevicesMountain View, US
Fletcher Wilson(Executive Officer, Director)
BoardThomas Fogarty(Director)Mel Schatz(Director)
Co-investorsLaunchCapitalRiverVest Venture PartnersEmergent Medical Partners, LLP
IT Asset Management Group provides IT asset disposition (ITAD), secure data destruction, and electronics recycling services for retired IT equipment.
Circular EconomyEnterprise Software
Co-investorsEmergent Medical Partners, LLP
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
BoardKirk Nielsen(Director)in
Co-investorsHatteras Venture PartnersVensana Capital
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.
Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US
Todd Berg(Executive Officer, Director)David H. Chung(Executive Officer, Director)Ron Nelson(Executive Officer)
BoardCasey Tansey(Director)Mudit K. Jain(Director)Andrew ElBardissi(Director)in
Co-investorsUS Venture PartnersDeerfield Management Company
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)Dave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)
Co-investorsCerity Partners VenturesForeground CapitalPortfoliaWindham Capital PartnersAction Potential Venture Capital Ltd.Vertex Ventures HC
SecondWave Systems develops a noninvasive, wearable ultrasound stimulation device that modulates nerves, cells, and organs deep in the body for at-home treatment of conditions such as inflammation and pain.
Digital HealthHardwareMedical Devices
Anuj Bhardwaj(Chief Executive Officer)Hubert H. Lim(Chief Scientific Officer)Jeff Heyman(Chief Operating Officer)
Co-investorsScientific Health Development
Exits · 1
IPOs and acquisitions across the tracked portfolioCVRxNASDAQ: CVRX
Portfolio news
latest coverage across their companiesCVRx · tradersunion.com · Jul 7, 2026
Avivomed · ainvest.com · Apr 21, 2026
Noctrix Health · nasdaqprivatemarket.com · Apr 3, 2026
NuXcel · finsmes.com · Nov 11, 2025
Frequently asked questions
- How many investments has Treo Ventures, Llc made?
- Treo Ventures, Llc has 12 tracked investments, including 3 dated in the last 24 months.
- What stage does Treo Ventures, Llc invest at?
- Treo Ventures, Llc invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What sectors does Treo Ventures, Llc focus on?
- Treo Ventures, Llc focuses on Digital Health, Healthtech, Medical Devices.
- Where is Treo Ventures, Llc located?
- Treo Ventures, Llc is headquartered in Minneapolis, US.
- Who does Treo Ventures, Llc co-invest with?
- Treo Ventures, Llc most often shares deals with US Venture Partners, Windham Capital Partners, Canaan Partners, among 26 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.